HALO logo
halo search icon
MacroGenics, Inc.
MacroGenics, Inc.
MGNX · NAS

MacroGenics, Inc.

US$4.46

Price Arrow-0.06 (-1.327%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleEngulfing BearishHALO AllHALO Earnings MomentumHALO MomentumHALO Price Momentum+4
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

MacroGenics, Inc. Overview

MGNX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About MGNX

icon

Telephone

1.301.251.5172

icon

Address

9704 Medical Center Drive, Rockville, MD 20850-3368

Description

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy E. Hood, Ruedi Aebersold, and Alan Aderem on August 14, 2000 and is headquartered in Rockville, MD.

MGNX Price Chart

Key Stats

Market Cap

US$287.31M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.18 - 4.64

Trade Value (12mth)

US$603,518.00

1 week

6.35%

1 month

30.26%

YTD

180.75%

1 year

203.36%

All time high

41.00

Key Fundamentals

EPS 3 yr Growth

-39.40%

EBITDA Margin

-43.90%

Operating Cashflow

-$81m

Free Cash Flow Return

-53.00%

ROIC

-48.80%

Interest Coverage

-7.70

Quick Ratio

4.90

Other Data

Shares Outstanding (Fully Diluted)

63m

HALO Sector

Healthcare

Next Company Report Date

25-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

MGNX Announcements

Latest Announcements

DateAnnouncements
21 May 26
21 May 26
14 May 26
14 May 26
14 May 26

MGNX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.15-1.07-1.18locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.15-1.07-1.18locklocklock
Growth
%locklocklocklock92.5-631-10.5locklocklock
PE
Xlocklocklocklock50.4N/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of MacroGenics, Inc. (MGNX:NAS)?
Halo FAQ
The current share price of MacroGenics, Inc. (MGNX:NAS) is USD$4.46.
What is the 52-week high share price for MacroGenics, Inc. (MGNX:NAS)?
Halo FAQ
The 52-week high share price for MacroGenics, Inc. (MGNX:NAS) is USD$4.64.
What is the 52-week low share price for MacroGenics, Inc. (MGNX:NAS)?
Halo FAQ
The 52-week low share price for MacroGenics, Inc. (MGNX:NAS) is USD$1.18.
What is the dividend yield for MacroGenics, Inc. (MGNX:NAS)?
Halo FAQ
MacroGenics, Inc. (MGNX:NAS) does not pay a dividend.
What was MacroGenics, Inc. (MGNX:NAS) last dividend payment?
Halo FAQ
MacroGenics, Inc. (MGNX:NAS) does not pay a dividend.
What is the franking level for MacroGenics, Inc. (MGNX:NAS)?
Halo FAQ
MacroGenics, Inc. (MGNX:NAS) has a franking level of 0.00%.
In which sector is MacroGenics, Inc. (MGNX:NAS) classified?
Halo FAQ
MacroGenics, Inc. (MGNX:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.